美国Caliper  www.caliperls.com
美国Caliper Life Sciences主要为在生命科学领域内致力于挽救生命、快速有效地提高药效和诊断测试水平的研究人员提供尖端技术。公司正积极通过技术创新来缩小体内和体外实验结果之间的差距，并研究如何有效地将之应用于疾病的治疗。该公司的主要产品包括先进的微流体、实验室自动化和液体处理、光学成像及开发外包方案等。
2006年Caliper 收购 Xenogen公司
2011年珀金埃尔默(PerkinElmer)6亿美元收购Caliper

        






Caliper Life Sciences (NASDAQ: CALP) is a leading provider of cutting-edge technologies enabling researchers in the life sciences to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper has compiled numerous best-in-class solutions and is aggressively innovating new technologies to bridge the gaps that exist in bringing in vitro assays to in vivo results and ultimately into cures for human disease. With a keen focus on clinically-relevant experimentation, Caliper’s portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions.

Our company represents a community of intelligent, highly-motivated people dedicated to working together as a team to improve the human condition through innovation in life sciences research. We maintain world headquarters in Hopkinton, Massachusetts, and direct sales, service and application-support operations in biopharmaceutically-active countries around the globe. Caliper’s customers and partners include leading pharmaceutical companies like Pfizer, GlaxoSmithKline, Sanofi-Aventis, Novartis, and AstraZeneca, among others.